Bremmer F, Behnes C L, Radzun H-J, Bettstetter M, Schweyer S
Institut für Pathologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland,
Pathologe. 2014 May;35(3):245-51. doi: 10.1007/s00292-014-1901-7.
According to the World Health Organization (WHO) classification from 2004, sex cord gonadal stromal tumors are divided into Leydig cell tumors, Sertoli cell tumors, granulosa cell tumors, tumors of the thecoma-fibroma group, incompletely differentiated sex cord gonadal stromal tumors, mixed forms of sex cord gonadal stromal tumors and tumors containing both germ cell and sex cord gonadal stromal elements. These tumors can appear sporadically or in combination with hereditary syndromes. To diagnose these rare tumors the combination of characteristic morphological aspects and various immunohistochemical markers is useful. Latest investigations demonstrate the potential role of mutation analyses in the diagnosis of this heterogeneous group of tumors.
根据世界卫生组织(WHO)2004年的分类,性索-性腺间质肿瘤分为莱迪希细胞瘤、支持细胞瘤、颗粒细胞瘤、卵泡膜-纤维瘤组肿瘤、未完全分化的性索-性腺间质肿瘤、性索-性腺间质肿瘤的混合形式以及含有生殖细胞和性索-性腺间质成分的肿瘤。这些肿瘤可散发性出现或与遗传性综合征合并出现。诊断这些罕见肿瘤时,结合特征性形态学表现和各种免疫组化标志物很有用。最新研究表明突变分析在诊断这一异质性肿瘤组中具有潜在作用。